tradingkey.logo
tradingkey.logo
検索

Labcorp Holdings Inc

LH
ウォッチリストに追加
271.470USD
0.0000.00%
終値 06/26, 16:00ET15分遅れの株価
22.34B時価総額
23.89直近12ヶ月PER

詳細情報 Labcorp Holdings Inc 企業名

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Labcorp Holdings Incの企業情報

企業コードLH
会社名Labcorp Holdings Inc
上場日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)
従業員数70000
証券種類Ordinary Share
決算期末Apr 24
本社所在地358 S Main St
都市BURLINGTON
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号27215
電話番号13362291127
ウェブサイトhttps://www.labcorp.com/
企業コードLH
上場日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)

Labcorp Holdings Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
9.85K
+2.92%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
7.88K
+27.39%
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
Ms. Anita Z. Graham
Ms. Anita Z. Graham
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
5.18K
+71.84%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--

よくある質問

Labcorp Holdings Incの上位5名の株主は誰ですか?

Labcorp Holdings Incの上位5名の株主は以下のとおりです。Mr. Adam H. Schechter

Labcorp Holdings Inc(LH)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Labcorp Holdings Incの株式を保有している機関は1855社あり、保有株式の総市場価値は約88.74Mで、全体の108.22%を占めています。2025Q4と比較して、機関の持ち株は5570263.00増加しています。
KeyAI